Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4075 EUR | +2.90% | -7.07% | -11.41% |
Chart calendar GenSight Biologics S.A.
Upcoming events on GenSight Biologics S.A.
Past events on GenSight Biologics S.A.
2024-03-22 01:00 pm | Q4 2023 Earnings Release |
2024-01-24 | Q4 2023 Sales and Revenue Release |
2023-10-26 12:00 pm | Q3 2023 Sales and Revenue Release |
2023-07-25 | Q2 2023 Earnings Release |
2023-06-20 | Annual General Meeting |
2023-04-26 11:30 am | Association for Research in Vision and Ophthalmology Meeting - Alfredo A. Sadun |
2023-04-24 05:15 pm | Association for Research in Vision and Ophthalmology Meeting - Chiara La Morgia |
2023-04-24 05:00 pm | Association for Research in Vision and Ophthalmology Meeting - Patrick Yu-Wai-Man |
2023-04-24 12:03 pm | American Academy of Neurology Meeting - Valérie Biousse |
2023-04-24 11:51 am | American Academy of Neurology Meeting - Nancy J. Newman |
2023-04-20 10:30 am | Business Update Call |
2023-04-19 | Q1 2023 Sales and Revenue Release |
2023-04-05 08:00 am | Business Update Call |
2023-03-24 02:30 am | Q4 2022 Earnings Release |
2023-03-14 06:30 pm | North American Neuro-Ophthalmology Society Meeting - Poster No: 279 |
2023-03-14 06:00 pm | North American Neuro Ophthalmology Society Meeting - Mark L. Moster |
2023-03-14 06:00 pm | North American Neuro Ophthalmology Society Meeting - Patrick Yu-Wai-Man |
2023-03-14 06:00 pm | North American Neuro Ophthalmology Society Meeting - Catherine Vignal |
2023-03-14 06:00 pm | North American Neuro Ophthalmology Society Meeting - Alfredo A. Sadun |
2023-01-26 01:30 am | FY 2022 Sales and Revenue Release |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 4,30 6,80 -36.76% | 4,90 7,10 -30.99% | 7,40 9,33 -20.71% | 7,70 12,5 -38.24% | 4,90 4,30 13.95% | 3,00 2,20 36.36% |
EBITDA Million EUR | Released Forecast Spread | -32,7 -24,7 -32.15% | -29,3 -27,5 -6.42% | -24,0 -18,0 -33.27% | -27,2 -23,0 -18.51% | -26,8 -36,7 27.05% | 0,00 -26,1 - |
EBIT Million EUR | Released Forecast Spread | -33,0 -24,9 -32.53% | -30,3 -27,7 -9.4% | -24,9 -18,4 -35.55% | -28,1 -22,1 -27.15% | -27,8 -37,6 26.06% | -29,7 -27,2 -9.19% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -33,5 -22,8 -47.05% | -30,7 -29,4 -4.45% | -34,0 -18,9 -79.73% | -28,6 -23,2 -23.61% | -27,6 -33,4 17.31% | 0,00 0,00 - |
Net income Million EUR | Released Forecast Spread | -33,5 -24,2 -38.24% | -30,7 -27,7 -10.65% | -34,0 -18,9 -79.66% | -28,6 -23,4 -22.22% | -27,6 -36,7 24.69% | -26,2 -26,3 0.38% |
EPS EUR | Released Forecast Spread | -1,37 -0,98 -40.27% | -1,08 -0,96 -11.94% | -0,97 -0,53 -81.88% | -0,63 -0,50 -26% | -0,60 -0,80 25% | -0,54 -0,58 6.9% |
Announcement Date | 24/04/19 | 12/03/20 | 10/03/21 | 08/04/22 | 24/03/23 | 22/03/24 |
Quarterly results
Fiscal Period | December | 2019 S1 |
---|---|---|
Net income Million EUR | Released Forecast Spread | -17,3 -15,2 -13.82% |
Announcement Date | 24/07/19 |
Past sector events for GenSight Biologics S.A.
Today | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
2024-03-27 07:00 am | ALTIMMUNE, INC.: Q4 2023 Earnings Release |
2024-03-26 | LEPU BIOPHARMA CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | REMEGEN CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | PHILOGEN S.P.A.: Q4 2023 Earnings Release |
2024-03-26 | ASCENTAGE PHARMA GROUP INTERNATIONAL: Q4 2023 Earnings Release |
2024-03-26 01:16 pm | KEYMED BIOSCIENCES INC.: Q4 2023 Earnings Release |
2024-03-24 | IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.: Q4 2023 Earnings Release |
2024-03-24 | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-21 04:01 pm | DIANTHUS THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock GenSight Biologics S.A. - Euronext Paris
- Calendar GenSight Biologics S.A.